Press release
University of Dundee spinout Amphista Therapeutics today announced the delivery of the first discovery milestone under a collaboration and licence agreement with global biopharmaceutical company Bristol Myers Squibb.
Press release
University of Dundee spinout Amphista Therapeutics today announced the delivery of the first discovery milestone under a collaboration and licence agreement with global biopharmaceutical company Bristol Myers Squibb.
Press release
University of Dundee spinout company Tay Therapeutics has announced a licensing deal potentially worth over $50 million in upfront and milestone payments, plus royalties.
Press release
World-leading and collaborative research undertaken at the University of Dundee has been honoured at one of the Life Sciences sector’s most prestigious award ceremonies.
Press release
A new University of Dundee spinout opportunity hopes to create vaccines against Strep A as well as novel vaccines for other human and animal diseases, while reducing our reliance on antibiotics.
News
The Drug Discovery Unit (DDU) is delighted to announce that Professor Ian Gilbert has been appointed to be the Head of the Drug Discovery Unit
Press release
University of Dundee researcher Professor Doreen Cantrell has been appointed as a trustee of one of the world’s biggest cancer charities.
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases.
News
Professor Julian Blow has been announced as the new Chair of the Lister Institute Scientific Advisory Committee (SAC).
News
UK Biobank recently announced the appointment of Professor Sir Michael Ferguson to its Board.
News
Professor Vicky Cowling has taken up a new position as a Senior Group Leader at the Cancer Research UK (CRUK) Beatson Institute in Glasgow.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
News
William Farnaby has been appointed as Principal Investigator within the newly formed Centre for Targeted Protein Degradation (CeTPD).
News
Professor Paul Wyatt, Head of the Drug Discovery Unit (DDU), Director of the Wellcome Centre for Anti-Infectives Research is leaving the University to take up a new role at Sitala Bio Ltd.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.
News
Dr Susan Wyllie, Head of the Mode of Action group within WCAIR and Principal Investigator in the School of Life Sciences, underwent a successful tenure review recently.
News
Dr Christina Schilde has been appointed as a lecturer as part of the D’Arcy Thompson Unit.
Press release
A University of Dundee-led programme that will train the next generation of barley researchers has received a multi-million pound investment.
News
Kirby Swatek will open an independent research laboratory in the MRC PPU at the beginning of 2022.
News
Professor Kim Dale has been appointed as Assistant Vice-Principal (International) for the University of Dundee.